Literature DB >> 14624799

Validation of the 'Marburg bone bank system' for thermodisinfection of allogenic femoral head transplants using selected bacteria, fungi, and spores.

Axel Pruss1, Michael Seibold, Frank Benedix, Lars Frommelt, Thomas von Garrel, Lutz Gürtler, Yvonne Dörffel, Georg Pauli, Ulf Berthold Göbel.   

Abstract

The Marburg Bone Bank System 'Lobator sd-2' is widely used to process human femoral heads removed during aseptic surgery by thermal disinfection. The inactivating capacity of the thermodisinfection system was validated in compliance with current standards using a newly developed femoral head model. The following micro-organisms, bacteria and fungi, taken from the American Type Culture Collection were investigated: Staphylococcus aureus, Staphyloccus epidermidis, Enterococcus faecium, Pseudomonas aeruginosa, Bacillus subtilis including spores, Clostridium sporogenes, Mycobacterium terrae, Candida albicans and Aspergillus niger spores. Highly enriched suspensions of these micro-organisms were applied to the centre of the femoral heads. The reduction in the number of micro-organisms was determined by counting the colony-forming units (cfu) before and after processing the spiked test device in the 'Lobator sd-2' system. Vegetative bacteria, fungi and fungal spores were completely inactivated (reduction factor >/=6 log(10)). The numbers of B. subtilis and C. sporogenes spores, both known to be heat-resistant, were reduced by one to two orders of magnitude. These bacteria serve as a model for spore forming pathogens which are not relevant in femoral heads from living donors. By processing human femoral heads from living donors by thermal disinfection using the Marburg Bone Banking system, a high level of safety is achieved regarding clinically relevant pathogens. To further increase the safety of the thermally treated femoral heads, we recommend that the medical history and present state of the donor, as well as the necessary serological tests should be taken into account.

Entities:  

Mesh:

Year:  2003        PMID: 14624799     DOI: 10.1016/j.biologicals.2003.08.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  20 in total

Review 1.  [Approval of a bone bank: an institution's experience].

Authors:  S Jung; D Wernerus; H Reichel
Journal:  Orthopade       Date:  2012-03       Impact factor: 1.087

Review 2.  [Bridging posttraumatic bony defects. Established and new methods].

Authors:  M Schieker; W Mutschler
Journal:  Unfallchirurg       Date:  2006-09       Impact factor: 1.000

3.  [Analysis of the effectiveness of an internal hospital bone bank].

Authors:  M Flören; T Kappe; H Reichel
Journal:  Orthopade       Date:  2007-07       Impact factor: 1.087

4.  [Musculoskeletal tissue banks. Legal foundations and graft safety].

Authors:  A Prub; B-D Katthagen
Journal:  Orthopade       Date:  2008-08       Impact factor: 1.087

5.  [Bone allografting].

Authors:  B-D Katthagen; A Prub
Journal:  Orthopade       Date:  2008-08       Impact factor: 1.087

6.  Validation of the Microbiological Testing of Tissue Preparations Using the BACTEC™ Blood Culture System.

Authors:  Jan Schroeter; Ina Wilkemeyer; Reinhold A Schiller; Axel Pruss
Journal:  Transfus Med Hemother       Date:  2012-11-21       Impact factor: 3.747

Review 7.  [Prevention of infections due to musculoskeletal allografts].

Authors:  A Pruß
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

Review 8.  [Influence of thermodisinfection on impaction of cancellous bone : An in vitro model of femoral impaction bone grafting].

Authors:  C Fölsch; A Jahnke; A Groß; G Martels; G A Krombach; M Rickert; M Kampschulte
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

Review 9.  [Bone banks : The state-of-the-art].

Authors:  A Pruß; U Kalus
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

10.  [Consequence of European Directive 2004/23/EC for bone banks in Germany].

Authors:  A Pruss; H Knaepler; B-D Katthagen; L Frommelt
Journal:  Orthopade       Date:  2005-11       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.